TARRYTOWN, N.Y., July 20, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Regeneron's ...

The U.S Food and Drug Administration is authorizing Regeneron's antibody cocktail for some patients who test positive for COVID-19. The FDA said Saturday that it's okay to give it to high-risk ...

New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail was able to prevent symptomatic Covid-19 among people exposed to the virus, the company said Monday. New Phase 3 ...

Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...

Roche and Regeneron’s COVID-19 antibody cocktail has demonstrated positive results in a phase 3 trial assessing the investigational treatment in infected non-hospitalised patients. The late-stage ...

Nov 21 (Reuters) - The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc's (REGN.O), opens new tab COVID-19 antibody therapy, an ...

President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this ...

TARRYTOWN, N.Y. - Regeneron Pharmaceuticals said Monday that a single dose of its antibody treatment reduced the risk of contracting COVID-19 by 81.6% for up to eight months, according to its ...

Last year, former president Donald Trump called monoclonal antibodies a "cure" for COVID-19 and vowed to make them available for all Americans. After all, they were part of Trump's own treatment that ...

As President Trump tests positive for coronavirus, investors and health officials worry over the state of the vaccine race and testing. Dr. Isaac Bogach, an Infectious Diseases Specialist, joins The ...